T. Rowe Price Associates »

Aikido Pharma shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Aikido Pharma (DOMH) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Aikido Pharma

Tip: Access up to 7 years of quarterly data

All positions including Aikido Pharma held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aikido Pharma by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $63k 19k 3.28
2025-12-31 $96k 19k 5.00

More positions owned by T. Rowe Price Associates

Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Microsoft Corp Comm Stk (MSFT)
Broadcom Comm Stk (AVGO)
Amazon Comm Stk (AMZN)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Netflix Comm Stk (NFLX)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Jpmorgan Chase & Co Comm Stk (JPM)
Ge Aerospace Comm Stk (GE)

View all positions for T. Rowe Price Associates

Top funds holding Aikido Pharma

Creek Drive Management Group
Vanguard Capital Management
Renaissance Technologies
BlackRock
Connective Capital Management
Geode Capital Management
State Street Corporation
Vanguard Fiduciary Trust
Steward Partners Investment Advisory
Morgan Stanley
Citadel Advisors
XTX Topco
Cambridge Investment Research Advisors
T. Rowe Price Associates
Northern Trust

View all funds holding Aikido Pharma